ArticleJournal of medicinal chemistry2007

Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: semisynthetic modifications and antifungal lead-exploration studies.

Abbas Gholipour Shilabin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.